WO2006032053A3 - Methods of treating symptoms of multiple sclerosis using vitamin d and related compounds - Google Patents
Methods of treating symptoms of multiple sclerosis using vitamin d and related compounds Download PDFInfo
- Publication number
- WO2006032053A3 WO2006032053A3 PCT/US2005/033421 US2005033421W WO2006032053A3 WO 2006032053 A3 WO2006032053 A3 WO 2006032053A3 US 2005033421 W US2005033421 W US 2005033421W WO 2006032053 A3 WO2006032053 A3 WO 2006032053A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- multiple sclerosis
- vitamin
- methods
- related compounds
- treating symptoms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002580564A CA2580564A1 (en) | 2004-09-14 | 2005-09-14 | Methods of treating symptoms of multiple sclerosis using vitamin d and related compounds |
EP05798310A EP1796680A2 (en) | 2004-09-14 | 2005-09-14 | Methods of treating symptoms of multiple sclerosis using vitamin d and related compounds |
IL181762A IL181762A0 (en) | 2004-09-14 | 2007-03-07 | Methods of treating symptoms of multiple sclerosis using vitamin d and related compounds |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60965104P | 2004-09-14 | 2004-09-14 | |
US60/609,651 | 2004-09-14 | ||
US62364904P | 2004-10-28 | 2004-10-28 | |
US62374404P | 2004-10-28 | 2004-10-28 | |
US60/623,649 | 2004-10-28 | ||
US60/623,744 | 2004-10-28 | ||
US69725805P | 2005-07-06 | 2005-07-06 | |
US60/697,258 | 2005-07-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006032053A2 WO2006032053A2 (en) | 2006-03-23 |
WO2006032053A3 true WO2006032053A3 (en) | 2006-09-08 |
Family
ID=36060740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/033421 WO2006032053A2 (en) | 2004-09-14 | 2005-09-14 | Methods of treating symptoms of multiple sclerosis using vitamin d and related compounds |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1796680A2 (en) |
CA (1) | CA2580564A1 (en) |
IL (1) | IL181762A0 (en) |
WO (1) | WO2006032053A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0513984D0 (en) * | 2005-07-07 | 2005-08-17 | Teva Pharma | Dosage form |
US20090221538A1 (en) * | 2008-02-01 | 2009-09-03 | Hayes Colleen E | Methods of treating multiple sclerosis by administering pulse dose calcitriol |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716946A (en) * | 1996-02-13 | 1998-02-10 | Wisconsin Alumni Research Foundation | Multiple sclerosis treatment |
US6214791B1 (en) * | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
US6369099B1 (en) * | 1998-05-21 | 2002-04-09 | Wisconsin Alumni Research Foundation | Method of locking 1 α-OH of vitamin D compounds in axial orientation |
-
2005
- 2005-09-14 WO PCT/US2005/033421 patent/WO2006032053A2/en active Application Filing
- 2005-09-14 EP EP05798310A patent/EP1796680A2/en not_active Withdrawn
- 2005-09-14 CA CA002580564A patent/CA2580564A1/en not_active Abandoned
-
2007
- 2007-03-07 IL IL181762A patent/IL181762A0/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716946A (en) * | 1996-02-13 | 1998-02-10 | Wisconsin Alumni Research Foundation | Multiple sclerosis treatment |
US6214791B1 (en) * | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
US6369099B1 (en) * | 1998-05-21 | 2002-04-09 | Wisconsin Alumni Research Foundation | Method of locking 1 α-OH of vitamin D compounds in axial orientation |
Also Published As
Publication number | Publication date |
---|---|
EP1796680A2 (en) | 2007-06-20 |
IL181762A0 (en) | 2007-07-04 |
WO2006032053A2 (en) | 2006-03-23 |
CA2580564A1 (en) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
WO2006119958A3 (en) | Use of flibanserin in the treatment of chronic pain | |
WO2007131154A3 (en) | Using naltrexone as a multi-purpose health supplement to improve the human condition and preventing multiple diseases and infirmities by stimulating immune system vitality and robustness | |
WO2004103297A3 (en) | Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis | |
WO2005116088A3 (en) | Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells | |
WO2007058990A3 (en) | Therapy using cytokine inhibitors | |
WO2006009874A3 (en) | Methods and compositions for treatment of excess nitric oxide or cyanide toxicity | |
WO2004110380A3 (en) | Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents | |
WO2004096216A3 (en) | Use of a topical medicament comprising riluzole | |
WO2006002096A3 (en) | Low doses of l-citrulline for treating diseases | |
WO2008012796A3 (en) | Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation | |
WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
WO2007006732A8 (en) | Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist) | |
WO2008016640A3 (en) | Use of poloxamer for the prevention and/or treatment of heart failure | |
TW200724146A (en) | Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant | |
WO2008045378A3 (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin | |
WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
WO2007130501A3 (en) | Combination therapy for treatment of cancer | |
WO2005092062A3 (en) | Compounds for neurodegenerative disorders | |
WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
WO2003097050A3 (en) | A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases | |
WO2005020908A3 (en) | Selective inhibitors of stat-3 activation and uses thereof | |
PL1656131T3 (en) | Use of betaine for treating intermittent claudication | |
WO2005123777A3 (en) | Method of treating granuloma annulare or sarcoid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 181762 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2580564 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005798310 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005798310 Country of ref document: EP |